These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34584567)

  • 1. Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity.
    Morita N; Hoshi M; Hara T; Ninomiya S; Enoki T; Yoneda M; Tsurumi H; Saito K
    Oncol Lett; 2021 Nov; 22(5):790. PubMed ID: 34584567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.
    Oxenkrug G; van der Hart M; Roeser J; Summergrad P
    Integr Clin Med; 2017; 1(1):. PubMed ID: 28748226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.
    Tashita C; Hoshi M; Hirata A; Nakamoto K; Ando T; Hattori T; Yamamoto Y; Tezuka H; Tomita H; Hara A; Saito K
    World J Gastroenterol; 2020 Mar; 26(9):918-932. PubMed ID: 32206003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenine 3-monooxygenase limits de novo NAD
    Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol F exposure induces depression-like changes: Roles of the kynurenine metabolic pathway along the "liver-brain" axis.
    Yu Z; Lin Y; Wu L; Wang L; Fan Y; Xu L; Zhang L; Wu W; Tao J; Huan F; Liu W; Wang J; Gao R
    Environ Pollut; 2024 Apr; 346():123356. PubMed ID: 38266696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Study Between Kynurenine 3-Monooxygenase (KMO) Gene and Parkinson's Disease Patients.
    Babu HWS; Elangovan A; Iyer M; Kirola L; Muthusamy S; Jeeth P; Muthukumar S; Vanlalpeka H; Gopalakrishnan AV; Kadhirvel S; Kumar NS; Vellingiri B
    Mol Neurobiol; 2024 Jul; 61(7):3867-3881. PubMed ID: 38040995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
    Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A
    Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine 3-monooxygenase from Pseudomonas fluorescens: substrate-like inhibitors both stimulate flavin reduction and stabilize the flavin-peroxo intermediate yet result in the production of hydrogen peroxide.
    Crozier-Reabe KR; Phillips RS; Moran GR
    Biochemistry; 2008 Nov; 47(47):12420-33. PubMed ID: 18954092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
    Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas.
    Vázquez Cervantes GI; Pineda B; Ramírez Ortega D; Salazar A; González Esquivel DF; Rembao D; Zavala Vega S; Gómez-Manzo S; Pérez de la Cruz G; Pérez de la Cruz V
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indoleamine 2, 3-dioxygenasase (IDO) as a prognostic factor of hematological malignancies].
    Hara T; Tsurumi H
    Rinsho Byori; 2011 Dec; 59(12):1133-43. PubMed ID: 22338916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
    Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
    Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease.
    Pires AS; Gupta S; Barton SA; Vander Wall R; Tan V; Heng B; Phillips JK; Guillemin GJ
    Int J Tryptophan Res; 2022; 15():11786469221126063. PubMed ID: 36329761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes.
    Fiedorowicz M; Choragiewicz T; Thaler S; Schuettauf F; Nowakowska D; Wojtunik K; Reibaldi M; Avitabile T; Kocki T; Turski WA; Kaminska A; Grieb P; Zrenner E; Rejdak R; Toro MD
    Front Physiol; 2019; 10():1254. PubMed ID: 31632294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
    Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
    Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model.
    Rojewska E; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Pharmacol; 2018; 9():724. PubMed ID: 30050435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma.
    Liu IL; Chung TF; Huang WH; Hsu CH; Liu CC; Chiu YH; Huang KC; Liao AT; Lin CS
    Vet Comp Oncol; 2021 Mar; 19(1):79-91. PubMed ID: 32720434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
    Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W
    Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.